FDA Nixes Wider Use of Iron Therapy

(MedPage Today) -- The FDA has turned down wider use of the iron therapy ferumoxytol (Feraheme), currently limited to use in patients with chronic kidney disease, the drug's manufacturer announced Wednesday.
Source: MedPage Today Public Health - Category: American Health Source Type: news